Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1995 Oct;102(1):174–180. doi: 10.1111/j.1365-2249.1995.tb06652.x

Autoantibodies against oxidized low density lipoproteins (oxLDL): characterization of antibody isotype, subclass, affinity and effect on the macrophage uptake of oxLDL.

R Wu 1, A K Lefvert 1
PMCID: PMC1553342  PMID: 7554386

Abstract

Circulating antibodies against oxLDL are present in several inflammatory and autoimmune conditions. Such antibodies are also present in patients with atherosclerosis, although the pathogenic significance of the antibodies is still not known. We have characterized the antibodies with regard to isotype, subclass, affinity and effect on macrophage uptake of oxLDL. Antibodies of IgG and IgM isotype were most common and found both in patients with atherosclerosis and in normal individuals. The subclass of IgG antibodies was mainly IgG2 and IgG3. Scatchard analyses of IgG and IgM antibodies showed that IgG antibodies were heterogeneous with regard to affinity, whereas only one population of high-affinity antibodies was found in the IgM antibody population. The high-affinity populations had an average equilibrium constant (K0) of 8.84 x 10(9) M-1 for IgG antibodies and of 1.65 x 10(9) M-1 for IgM antibodies. Incubation of 125I-oxLDL with purified IgG and IgM from sera with high amounts of antibodies enhanced the uptake of 125I-oxLDL in the monocyte-like U937 cell line. Antibody preparations from sera containing no anti-oxLDL antibodies and from sera with antibodies against LDL had less effect on this uptake. The increased uptake was competitively decreased by adding unlabelled oxLDL. This study shows that antibodies against oxLDL are mainly IgG2, IgG3 and IgM. Both IgG and IgM antibodies have a high affinity for the antigen and increase the uptake of oxLDL in a monocyte-like cell line.

Full text

PDF
174

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adkinson N. F., Sobotka A. K., Lichtenstein L. M. Evaluation of the quantity and affinity of human IgG "blocking" antibodies. J Immunol. 1979 Mar;122(3):965–972. [PubMed] [Google Scholar]
  2. Arvieux J., Roussel B., Ponard D., Colomb M. G. IgG2 subclass restriction of anti-beta 2 glycoprotein 1 antibodies in autoimmune patients. Clin Exp Immunol. 1994 Feb;95(2):310–315. doi: 10.1111/j.1365-2249.1994.tb06529.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Avogaro P., Bon G. B., Cazzolato G. Presence of a modified low density lipoprotein in humans. Arteriosclerosis. 1988 Jan-Feb;8(1):79–87. [PubMed] [Google Scholar]
  4. Bergmark C., Wu R., de Faire U., Lefvert A. K., Swedenborg J. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arterioscler Thromb Vasc Biol. 1995 Apr;15(4):441–445. doi: 10.1161/01.atv.15.4.441. [DOI] [PubMed] [Google Scholar]
  5. Berliner J. A., Territo M. C., Sevanian A., Ramin S., Kim J. A., Bamshad B., Esterson M., Fogelman A. M. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest. 1990 Apr;85(4):1260–1266. doi: 10.1172/JCI114562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Branch D. W., Mitchell M. D., Miller E., Palinski W., Witztum J. L. Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein. Lancet. 1994 Mar 12;343(8898):645–646. doi: 10.1016/s0140-6736(94)92639-5. [DOI] [PubMed] [Google Scholar]
  7. Carlson K. Lipoprotein fractionation. J Clin Pathol Suppl (Assoc Clin Pathol) 1973;5:32–37. doi: 10.1136/jcp.s1-5.1.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Devey M. E., Voak D. A critical study of the IgG subclasses of Rh anti-D antibodies formed in pregnancy and in immunized volunteers. Immunology. 1974 Dec;27(6):1073–1079. [PMC free article] [PubMed] [Google Scholar]
  9. Eber B., Schumacher M., Tatzber F., Kaufmann P., Luha O., Esterbauer H., Klein W. Autoantibodies to oxidized low density lipoproteins in restenosis following coronary angioplasty. Cardiology. 1994;84(4-5):310–315. doi: 10.1159/000176417. [DOI] [PubMed] [Google Scholar]
  10. Frostegård J., Nilsson J., Haegerstrand A., Hamsten A., Wigzell H., Gidlund M. Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc Natl Acad Sci U S A. 1990 Feb;87(3):904–908. doi: 10.1073/pnas.87.3.904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. GREENWOOD F. C., HUNTER W. M., GLOVER J. S. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J. 1963 Oct;89:114–123. doi: 10.1042/bj0890114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Goldstein J. L., Ho Y. K., Basu S. K., Brown M. S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A. 1979 Jan;76(1):333–337. doi: 10.1073/pnas.76.1.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Grabar P. Hypothesis. Auto-antibodies and immunological theories: an analytical review. Clin Immunol Immunopathol. 1975 Nov;4(4):453–466. doi: 10.1016/0090-1229(75)90087-2. [DOI] [PubMed] [Google Scholar]
  14. Griffith R. L., Virella G. T., Stevenson H. C., Lopes-Virella M. F. Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation. J Exp Med. 1988 Sep 1;168(3):1041–1059. doi: 10.1084/jem.168.3.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. HAVEL R. J., EDER H. A., BRAGDON J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 Sep;34(9):1345–1353. doi: 10.1172/JCI103182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Henriksen T., Mahoney E. M., Steinberg D. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc Natl Acad Sci U S A. 1981 Oct;78(10):6499–6503. doi: 10.1073/pnas.78.10.6499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hessler J. R., Morel D. W., Lewis L. J., Chisolm G. M. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis. 1983 May-Jun;3(3):215–222. doi: 10.1161/01.atv.3.3.215. [DOI] [PubMed] [Google Scholar]
  18. Hessler J. R., Robertson A. L., Jr, Chisolm G. M., 3rd LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis. 1979 Mar;32(3):213–229. doi: 10.1016/0021-9150(79)90166-7. [DOI] [PubMed] [Google Scholar]
  19. Khoo J. C., Miller E., Pio F., Steinberg D., Witztum J. L. Monoclonal antibodies against LDL further enhance macrophage uptake of LDL aggregates. Arterioscler Thromb. 1992 Nov;12(11):1258–1266. doi: 10.1161/01.atv.12.11.1258. [DOI] [PubMed] [Google Scholar]
  20. Kiessling R., Grönberg A., Ivanyi J., Söderström K., Ferm M., Kleinau S., Nilsson E., Klareskog L. Role of hsp60 during autoimmune and bacterial inflammation. Immunol Rev. 1991 Jun;121:91–111. doi: 10.1111/j.1600-065x.1991.tb00824.x. [DOI] [PubMed] [Google Scholar]
  21. Klimov A. N., Denisenko A. D., Popov A. V., Nagornev V. A., Pleskov V. M., Vinogradov A. G., Denisenko T. V., Magracheva EYa, Kheifes G. M., Kuznetzov A. S. Lipoprotein-antibody immune complexes. Their catabolism and role in foam cell formation. Atherosclerosis. 1985 Dec;58(1-3):1–15. doi: 10.1016/0021-9150(85)90051-6. [DOI] [PubMed] [Google Scholar]
  22. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  23. Lopes-Virella M. F., Griffith R. L., Shunk K. A., Virella G. T. Enhanced uptake and impaired intracellular metabolism of low density lipoprotein complexed with anti-low density lipoprotein antibodies. Arterioscler Thromb. 1991 Sep-Oct;11(5):1356–1367. doi: 10.1161/01.atv.11.5.1356. [DOI] [PubMed] [Google Scholar]
  24. López-Bote J. P., Langa C., Lastres P., Rius C., Marquet A., Ramos-Ruiz R., Bernabéu C. Aggregated human immunoglobulins bind to modified proteins. Scand J Immunol. 1993 May;37(5):593–601. doi: 10.1111/j.1365-3083.1993.tb02577.x. [DOI] [PubMed] [Google Scholar]
  25. MCFARLANE A. S. Labelling of plasma proteins with radioactive iodine. Biochem J. 1956 Jan;62(1):135–143. doi: 10.1042/bj0620135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Maggi E., Finardi G., Poli M., Bollati P., Filipponi M., Stefano P. L., Paolini G., Grossi A., Clot P., Albano E. Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk. Coron Artery Dis. 1993 Dec;4(12):1119–1122. doi: 10.1097/00019501-199312000-00014. [DOI] [PubMed] [Google Scholar]
  27. Morel D. W., Hessler J. R., Chisolm G. M. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res. 1983 Aug;24(8):1070–1076. [PubMed] [Google Scholar]
  28. Nilson B., Björck L., Akerström B. Detection and purification of rat and goat immunoglobulin G antibodies using protein G-based solid-phase radioimmunoassays. J Immunol Methods. 1986 Jul 24;91(2):275–281. doi: 10.1016/0022-1759(86)90490-4. [DOI] [PubMed] [Google Scholar]
  29. Palinski W., Rosenfeld M. E., Ylä-Herttuala S., Gurtner G. C., Socher S. S., Butler S. W., Parthasarathy S., Carew T. E., Steinberg D., Witztum J. L. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A. 1989 Feb;86(4):1372–1376. doi: 10.1073/pnas.86.4.1372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Palinski W., Ylä-Herttuala S., Rosenfeld M. E., Butler S. W., Socher S. A., Parthasarathy S., Curtiss L. K., Witztum J. L. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis. 1990 May-Jun;10(3):325–335. doi: 10.1161/01.atv.10.3.325. [DOI] [PubMed] [Google Scholar]
  31. Parums D. V., Brown D. L., Mitchinson M. J. Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis. Arch Pathol Lab Med. 1990 Apr;114(4):383–387. [PubMed] [Google Scholar]
  32. Robboy S. J., Lewis E. J., Schur P. H., Colman R. W. Circulating anticoagulants to factor VIII. Immunochemical studies and clinical response to factor VIII concentrates. Am J Med. 1970 Dec;49(6):742–752. doi: 10.1016/s0002-9343(70)80056-0. [DOI] [PubMed] [Google Scholar]
  33. Salonen J. T., Ylä-Herttuala S., Yamamoto R., Butler S., Korpela H., Salonen R., Nyyssönen K., Palinski W., Witztum J. L. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet. 1992 Apr 11;339(8798):883–887. doi: 10.1016/0140-6736(92)90926-t. [DOI] [PubMed] [Google Scholar]
  34. Schumacher M., Eber B., Tatzber F., Kaufmann P., Esterbauer H., Klein W. LDL oxidation and coronary atherosclerosis. Lancet. 1992 Jul 11;340(8811):123–123. [PubMed] [Google Scholar]
  35. Sobotka A. K., Valentine M. D., Ishizaka K., Lichtenstein L. M. Measurement of IgG-blocking antibodies: development and application of a radioimmunoassay. J Immunol. 1976 Jul;117(1):84–90. [PubMed] [Google Scholar]
  36. Steinbrecher U. P., Parthasarathy S., Leake D. S., Witztum J. L., Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci U S A. 1984 Jun;81(12):3883–3887. doi: 10.1073/pnas.81.12.3883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Steinbrecher U. P., Zhang H. F., Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radic Biol Med. 1990;9(2):155–168. doi: 10.1016/0891-5849(90)90119-4. [DOI] [PubMed] [Google Scholar]
  38. Sundström C., Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer. 1976 May 15;17(5):565–577. doi: 10.1002/ijc.2910170504. [DOI] [PubMed] [Google Scholar]
  39. Vandvik B., Natvig J. B., Norrby E. IgG1 subclass restriction of oligoclonal measles virus-specific IgG antibodies in patients with subacute sclerosing panencephalitis and in a patient with multiple sclerosis. Scand J Immunol. 1977;6(6-7):651–657. doi: 10.1111/j.1365-3083.1977.tb02145.x. [DOI] [PubMed] [Google Scholar]
  40. Virella G., Virella I., Leman R. B., Pryor M. B., Lopes-Virella M. F. Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers. Int J Clin Lab Res. 1993;23(2):95–101. doi: 10.1007/BF02592290. [DOI] [PubMed] [Google Scholar]
  41. Witztum J. L., Steinbrecher U. P., Fisher M., Kesaniemi A. Nonenzymatic glucosylation of homologous low density lipoprotein and albumin renders them immunogenic in the guinea pig. Proc Natl Acad Sci U S A. 1983 May;80(9):2757–2761. doi: 10.1073/pnas.80.9.2757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med. 1976 Apr;15(2):212–216. doi: 10.1016/0006-2944(76)90049-1. [DOI] [PubMed] [Google Scholar]
  43. Ylä-Herttuala S., Palinski W., Butler S. W., Picard S., Steinberg D., Witztum J. L. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb. 1994 Jan;14(1):32–40. doi: 10.1161/01.atv.14.1.32. [DOI] [PubMed] [Google Scholar]
  44. Ylä-Herttuala S., Palinski W., Rosenfeld M. E., Parthasarathy S., Carew T. E., Butler S., Witztum J. L., Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989 Oct;84(4):1086–1095. doi: 10.1172/JCI114271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Yount W. J., Dorner M. M., Kunkel H. G., Kabat E. A. Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers. J Exp Med. 1968 Mar 1;127(3):633–646. doi: 10.1084/jem.127.3.633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Zhang H. F., Basra H. J., Steinbrecher U. P. Effects of oxidatively modified LDL on cholesterol esterification in cultured macrophages. J Lipid Res. 1990 Aug;31(8):1361–1369. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES